Steatosis News and Research

RSS
Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Dietary habits associated with NAFLD in obese children

Dietary habits associated with NAFLD in obese children

High uric acid precursor of obesity, metabolic syndrome

High uric acid precursor of obesity, metabolic syndrome

Usefulness of liver biopsy for CALI preoperative assessment questioned

Usefulness of liver biopsy for CALI preoperative assessment questioned

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Pediatric liver transplant recipients have increased risk of death when from obese donors

Pediatric liver transplant recipients have increased risk of death when from obese donors

Gilead receives FDA approval for Truvada to reduce risk of sexually acquired HIV-1 infection

Gilead receives FDA approval for Truvada to reduce risk of sexually acquired HIV-1 infection

Mouse model demonstrates role of AEG-1 in hepatocellular carcinoma

Mouse model demonstrates role of AEG-1 in hepatocellular carcinoma

People with fatty livers need to lose weight

People with fatty livers need to lose weight

Obese patients with fatty liver disease show only small benefit on lipoprotein levels with moderate exercise

Obese patients with fatty liver disease show only small benefit on lipoprotein levels with moderate exercise

FDA ADAC recommends approval of Gilead’s Truvada for HIV

FDA ADAC recommends approval of Gilead’s Truvada for HIV

EASL publishes new clinical practice guideline on ALD

EASL publishes new clinical practice guideline on ALD

Gut microbiota plays a causal role in development of diabetes and NAFLD

Gut microbiota plays a causal role in development of diabetes and NAFLD

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

Caffeine consumption reduces risk of advanced fibrosis in NAFLD patients

WSU professors receive NSF grant to develop math model of liver metabolism

WSU professors receive NSF grant to develop math model of liver metabolism

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Scientists identify A2bAR as possible new therapeutic target against atherosclerosis

Scientists identify A2bAR as possible new therapeutic target against atherosclerosis

Mediterranean Diet beneficial even without weight loss

Mediterranean Diet beneficial even without weight loss

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

FDA approves Gilead's Complera for treatment of HIV-1 infection

FDA approves Gilead's Complera for treatment of HIV-1 infection